Neogen (FRA:NG2) Total Stockholders Equity: €1,791.5 Mil (As of May. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:NG2 Neogen Corp FRA:NG2
69 GF Score
Price €9.92
GF Value €9.85
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Neogen Total Stockholders Equity?

Neogen FRA:NG2 +0.30% 69 Total Stockholders Equity is €1,791.5 Mil as of May. 2026. GuruFocus rates FRA:NG2 with a GF Score™ of 69/100 and a GF Value™ of €9.85 (Fairly Valued). The stock has 5 warning signs investors should review.

Neogen's Total Stockholders Equity for the quarter that ended in May. 2026 was €1,791.5 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Neogen's Book Value per Share for the quarter that ended in May. 2026 was €8.23. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Neogen's Debt-to-Equity for the quarter that ended in May. 2026 was 0.38.

Neogen  (FRA:NG2) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Neogen's Book Value per Share for the quarter that ended in May. 2026 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(1791.522-0)/217.700
=8.23

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Neogen's Debt-to-Equity for the quarter that ended in May. 2026 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0 + 679.407) / 1791.522
=0.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neogen Total Stockholders Equity Related Terms

Neogen Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Neogen's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neogen Total Stockholders Equity Chart

Neogen Annual Data
Trend May17 May18 May19 May20 May21 May22 May23 May24 May25 May26
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 839.46 2,883.48 2,908.33 1,837.15 1,791.52

Neogen Quarterly Data
Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26 May26
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,837.15 1,819.92 1,820.38 1,778.63 1,791.52
FRA:NG2
69GF Score
Neogen Corp FRA:NG2
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of €1,791.5 Mil mean?
Neogen (FRA:NG2) has a Total Stockholders Equity of €1,791.5 Mil as of May. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Neogen and its competitors.
Is Neogen's Total Stockholders Equity too high?
Neogen's current Total Stockholders Equity is €1,791.5 Mil. Overall, Neogen has a GF Score™ of 69/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Neogen's Total Stockholders Equity compare to UFPT and AXGN?
Neogen's Total Stockholders Equity of €1,791.5 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Medical Devices & Instruments company?
A good Total Stockholders Equity depends on the Medical Devices & Instruments industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Neogen and its competitors. Neogen's current Total Stockholders Equity is €1,791.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neogen stock overvalued right now?
Based on GuruFocus' analysis, Neogen (FRA:NG2) is currently considered Fairly Valued. The stock's GF Value™ is €9.85, compared to a current price of €9.92 — trading 0.8% above its estimated fair value. The current Total Stockholders Equity is €1,791.5 Mil. Neogen's overall GF Score™ is 69/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Neogen (FRA:NG2), the current Total Stockholders Equity is €1,791.5 Mil as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Neogen (FRA:NG2) Overvalued in 2026?

Based on GuruFocus' analysis, Neogen stock appears to be overvalued. The current stock price of €9.92 is trading 0.8% above its estimated GF Value™ of €9.85. GuruFocus considers Neogen to be Fairly Valued.

Key valuation signals for FRA:NG2:

  • Total Stockholders Equity: €1,791.5 Mil
  • GF Value™: €9.85 vs. price of €9.92 (0.8% above fair value)
  • GF Score™: 69/100 with 5 warning signs

No single metric tells the full story. See the FRA:NG2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Neogen Business Description

Other Exchanges NEOG:USANG2:Germany
Address 620 Lesher Place, Lansing, MI, USA, 48912
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.
69GF Score

Get the complete analysis for FRA:NG2

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€9.92
Price
€9.85
GF Value